Olverembatinib
Product Specifications
CAS Number
1257628-77-5
Target
Bcr-Abl
Related Pathways
Cytoskeletal Signaling, Tyrosine Kinase/Adaptors, Angiogenesis
Purity
>99.99%
Bioactivity
Olverembatinib (GZD 824) is an orally bioavailable Bcr-Abl inhibitor for Bcr-Abl (WT, IC50: 0.34 nM) and Bcr-Abl (T315I, IC50: 0.68 nM) .
Smiles
CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4[nH]ncc4c3)cc2C(F)(F)F)CC1
Molecular Formula
C29H27F3N6O
Molecular Weight
532.56
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6400459-01 0.1 mL
ELOVL7 (Elongation of Very Long Chain Fatty Acids Protein 7, 3-keto Acyl-CoA Synthase ELOVL7, ELOVL Fatty Acid Elongase 7, ELOVL FA Elongase 7, Very-long-chain 3-oxoacyl-CoA Synthase 7, FLJ23563) (PE)
Sign In for Pricing
View Details MBS6400459-02 5x 0.1 mL
ELOVL7 (Elongation of Very Long Chain Fatty Acids Protein 7, 3-keto Acyl-CoA Synthase ELOVL7, ELOVL Fatty Acid Elongase 7, ELOVL FA Elongase 7, Very-long-chain 3-oxoacyl-CoA Synthase 7, FLJ23563) (PE)
Sign In for Pricing
View Details IC171026 100 mg
2-[3-[4- (3-Chloro-4-ethylphenyl) -1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridin-3 (2H) -one
Sign In for Pricing
View Details orb2703677-01 1 mg
EphA2 Biosimilar (Sanofi Aventis patent EphA2 Reference Antibody)
Sign In for Pricing
View Details